Download PDF
J Pediatr Infect Dis 2021; 16(03): 106-110
DOI: 10.1055/s-0041-1724021
Original Article

Expression of MicroRNA of Macrophages Infected with Attenuated Leishmania major Parasite

Mohammad Hossein Feiz Haddad
1   Cellular and Molecular Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2   Department of Parasitology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
,
Hossein Rezvan
3   Department of Pathobiology, Faculty of Veterinary Science, Bu-Ali Sina University, Hamedan, Iran
,
Alireza Nourian
3   Department of Pathobiology, Faculty of Veterinary Science, Bu-Ali Sina University, Hamedan, Iran
,
Habib Habibpour
1   Cellular and Molecular Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2   Department of Parasitology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
› Author Affiliations Funding This study received financial support from Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (grant No. CMRC-9820).
› Further Information
    Permissions and Reprints

Abstract

Objective Leishmaniasis has been proposed as one of the neglected vector-borne diseases due to an obligate intracellular parasite of the genus Leishmania. MicroRNAs (miRNAs) with a length of 22-nucleotide are known as the noncoding small RNAs. MiRNAs contribute to many biological and cellular approaches. Therefore, the present study evaluated expressing mmu-miR-721, mmu-miR-294–3p, mmu-miR-155–3p, and mmu-miR-30a in murine macrophages infected with attenuated Leishmania major parasites on 3 days after infection.

Methods Attenuated promastigotes have been achieved after 20 passages of Leishmania major parasites. Cell line J774A.1 (murine macrophage) has been used for in vitro experiments. The stationary phase of attenuated L. major promastigotes has been chosen to infect the cells, and then their incubation has been performed with 5% CO2 at 37°C for 3 days. The real-time polymerase chain reaction (PCR) has also been performed with SYBR Green master-mix Kit for measuring the level of mmu-miR-721, mmu-miR-294–3p, mmu-miR-30a, and mmu-miR-155-3p expression. Uninfected macrophages have been considered as a control group.

Results Real-time PCR demonstrated overexpression of mmu-miR-155-3p, mmu-miR-294–3p, and, mmu-miR-721 in the infected cells with Leishmania parasites after 3 days. Results showed no statistically significant difference in the mmu-miR-30a expression between infected macrophages and the uninfected control group.

Conclusion Our findings suggested the significant contribution of the alterations in the miRNA levels to the regulation of macrophage functions following the creation of intracellular parasites like Leishmania. These data could help to understand better the genes' expression in the host cells in the course of leishmaniasis.

Keywords

microRNA - mmu-miR-294–3p - mmu-miR-721 - mmu-miR-155 -3p - mmu-miR-30a - Leishmania

Declaration

The manuscript is the original work of authors.


All data, tables, etc., used in the manuscript are prepared originally by authors, otherwise the sources are cited and reprint permission is attached.


The manuscript has not been and will not be published elsewhere or submitted elsewhere for publication.


Ethical Approval

The study protocol is done based on the Helsinki declaration and was confirmed by the ethics committee of the deputy of research of Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran (grant no.: IR.AJUMS.ABHC.REC.1398.074).




Publication History

Received: 03 September 2020

Accepted: 22 December 2020

Article published online:
25 February 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Hamoon Navard S, Rezvan H, Feiz Haddad MH. et al. Therapeutic effects of mesenchymal stem cells on cutaneous leishmaniasis lesions caused by Leishmania major . J Glob Antimicrob Resist 2020; 23: 243-250
    CrossrefPubMedGoogle Scholar
  • 2 McGwire BS, Satoskar AR. Leishmaniasis: clinical syndromes and treatment. QJM 2014; 107 (01) 7-14
    CrossrefPubMedGoogle Scholar
  • 3 Feiz-Haddad MH, Safaei K, Saki A, Feiz-Haddad R. Epidemiological study of cutaneous leishmaniasis in southwest of Iran during 2001–2011. Asian Pac J Trop Dis 2016; 6 (06) 432-436
    CrossrefPubMedGoogle Scholar
  • 4 Shokri A, Emami S, Fakhar M, Teshnizi SH, Keighobadi M. In vitro antileishmanial activity of novel azoles (3-imidazolylflavanones) against promastigote and amastigote stages of Leishmania major . Acta Trop 2017; 167: 73-78
    CrossrefPubMedGoogle Scholar
  • 5 Patwardhan V, Kumar D, Singh S. Parasitic infections in pediatric population of india: epidemiology, diagnosis, and strategies for prevention. J Pediatr Infect Dis 2017; 12 (04) 228-237
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Rezvan H, Moafi M. An overview on Leishmania vaccines: a narrative review article. Vet Res Forum 2015; 6 (01) 1-7
    PubMedGoogle Scholar
  • 7 Liu D, Uzonna JE. The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response. Front Cell Infect Microbiol 2012; 2: 83
    PubMedGoogle Scholar
  • 8 Merida-de-Barros DA, Chaves SP, Belmiro CLR, Wanderley JLM. Leishmaniasis and glycosaminoglycans: a future therapeutic strategy?. Parasit Vectors 2018; 11 (01) 536
    CrossrefPubMedGoogle Scholar
  • 9 Rossi M, Fasel N. How to master the host immune system? Leishmania parasites have the solutions!. Int Immunol 2018; 30 (03) 103-111
    CrossrefPubMedGoogle Scholar
  • 10 Gupta AK, Singh A, Srivastava S, Shankar P, Singh S. Visceral leishmaniasis in children: diagnosis, treatment, and prevention. J Pediatr Infect Dis 2017; 12 (04) 214-221
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Nawaz M. Nanotechnology-based approaches in pediatric parasitic infections. J Pediatr Infect Dis 2017; 12 (04) 264-270
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Shokri A, Saeedi M, Fakhar M. et al. Antileishmanial activity of Lavandula angustifolia and Rosmarinus officinalis essential oils and nano-emulsions on Leishmania major (MRHO/IR/75/ER). Iran J Parasitol 2017; 12 (04) 622-631
    PubMedGoogle Scholar
  • 13 Liu Q, Tuo W, Gao H, Zhu X-Q. MicroRNAs of parasites: current status and future perspectives. Parasitol Res 2010; 107 (03) 501-507
    CrossrefPubMedGoogle Scholar
  • 14 Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136 (02) 215-233
    CrossrefPubMedGoogle Scholar
  • 15 Rodriguez A, Vigorito E, Clare S. et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316 (5824): 608-611
    CrossrefPubMedGoogle Scholar
  • 16 Trotta R, Chen L, Ciarlariello D. et al. miR-155 regulates IFN-γ production in natural killer cells. Blood 2012; 119 (15) 3478-3485
    CrossrefPubMedGoogle Scholar
  • 17 Eren RO, Reverte M, Rossi M. et al. Mammalian innate immune response to a Leishmania-resident RNA virus increases macrophage survival to promote parasite persistence. Cell Host Microbe 2016; 20 (03) 318-328
    CrossrefPubMedGoogle Scholar
  • 18 Tili E, Michaille J-J, Cimino A. et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-α stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007; 179 (08) 5082-5089
    CrossrefPubMedGoogle Scholar
  • 19 Singh AK, Pandey RK, Shaha C, Madhubala R. MicroRNA expression profiling of Leishmania donovani-infected host cells uncovers the regulatory role of MIR30A-3p in host autophagy. Autophagy 2016; 12 (10) 1817-1831
    CrossrefPubMedGoogle Scholar
  • 20 Zhu H, Wu H, Liu X. et al. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy 2009; 5 (06) 816-823
    CrossrefPubMedGoogle Scholar
  • 21 Chen Z, Wang T, Liu Z. et al. Inhibition of autophagy by MiR-30A induced by mycobacteria tuberculosis as a possible mechanism of immune escape in human macrophages. Jpn J Infect Dis 2015; 68 (05) 420-424
    CrossrefPubMedGoogle Scholar
  • 22 Frank B, Marcu A, de Oliveira Almeida Petersen AL. et al. Autophagic digestion of Leishmania major by host macrophages is associated with differential expression of BNIP3, CTSE, and the miRNAs miR-101c, miR-129, and miR-210. Parasit Vectors 2015; 8: 404-404
    CrossrefPubMedGoogle Scholar
  • 23 Lemaire J, Mkannez G, Guerfali FZ. et al; Sysco-Consortium. MicroRNA expression profile in human macrophages in response to Leishmania major infection. PLoS Negl Trop Dis 2013; 7 (10) e2478
    CrossrefPubMedGoogle Scholar
  • 24 Ghosh J, Bose M, Roy S, Bhattacharyya SN. Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection. Cell Host Microbe 2013; 13 (03) 277-288
    CrossrefPubMedGoogle Scholar
  • 25 Geraci NS, Tan JC, McDowell MA. Characterization of microRNA expression profiles in Leishmania-infected human phagocytes. Parasite Immunol 2015; 37 (01) 43-51
    CrossrefPubMedGoogle Scholar
  • 26 Muxel SM, Laranjeira-Silva MF, Zampieri RA, Floeter-Winter LM. Leishmania (Leishmania) amazonensis induces macrophage miR-294 and miR-721 expression and modulates infection by targeting NOS2 and L-arginine metabolism. Sci Rep 2017; 7: 44141
    CrossrefPubMedGoogle Scholar
  • 27 Ali KS, Rees RC, Terrell-Nield C, Ali SA. Virulence loss and amastigote transformation failure determine host cell responses to Leishmania mexicana . Parasite Immunol 2013; 35 (12) 441-456
    CrossrefPubMedGoogle Scholar
  • 28 Moreira D, Santarém N, Loureiro I. et al. Impact of continuous axenic cultivation in Leishmania infantum virulence. PLoS Negl Trop Dis 2012; 6 (01) e1469
    CrossrefPubMedGoogle Scholar
  • 29 Noorpisheh Ghadimi S, Homayoon L, Shahriarirad R, Fatehpour S, Rastegarian M, Sarkari B. Attenuated Leishmania major induce a high level of protection against Leishmania infantum in BALB/c mice. Iran J Parasitol 2019; 14 (02) 310-317
    PubMedGoogle Scholar
  • 30 Hashemi N, Sharifi M, Tolouei S, Hashemi M, Hashemi C, Hejazi SH. Expression of hsa Let-7a MicroRNA of macrophages infected by Leishmania major . Int J Med Res Health Sci 2018; 5 (10) 27-32
    PubMedGoogle Scholar
  • 31 Hsu Y-A, Lin C-H, Lin H-J. et al. Effect of microRNA-155 on the interferon-gamma signaling pathway in biliary atresia. Chin J Physiol 2016; 59 (06) 315-322
    CrossrefPubMedGoogle Scholar
  • 32 Manzano-Román R, Siles-Lucas M. MicroRNAs in parasitic diseases: potential for diagnosis and targeting. Mol Biochem Parasitol 2012; 186 (02) 81-86
    CrossrefPubMedGoogle Scholar
  • 33 Lodish HF, Zhou B, Liu G, Chen C-Z. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008; 8 (02) 120-130
    CrossrefPubMedGoogle Scholar
  • 34 Rodriguez NE, Chang HK, Wilson ME. Novel program of macrophage gene expression induced by phagocytosis of Leishmania chagasi . Infect Immun 2004; 72 (04) 2111-2122
    CrossrefPubMedGoogle Scholar
  • 35 Lin Y, Sibanda VL, Zhang H-M, Hu H, Liu H, Guo A-Y. MiRNA and TF co-regulatory network analysis for the pathology and recurrence of myocardial infarction. Sci Rep 2015; 5: 9653
    CrossrefPubMedGoogle Scholar
  • 36 Qin Y, Wang Q, Zhou Y, Duan Y, Gao Q. Inhibition of IFN-γ-induced nitric oxide dependent antimycobacterial activity by miR-155 and C/EBPβ. Int J Mol Sci 2016; 17 (04) 535
    CrossrefPubMedGoogle Scholar
  • 37 Silva SC, Silva DF, Almeida TC. et al. Behavior of two Leishmania infantum strains-evaluation of susceptibility to antimonials and expression of microRNAs in experimentally infected J774 macrophages and in BALB/c mice. Parasitol Res 2018; 117 (09) 2881-2893
    CrossrefPubMedGoogle Scholar
  • 38 Wendlandt EB. Macrophage microRNA and mRNA responses to stimulation of TLRs or upon infection with Leishmania infantum chagasi [dissertation]. Iowa, Missouri: University of Iowa; 2013
    Google Scholar